Abstract
Gelatinous bone marrow transformation (GTBM) also known as serous atrophy is a degenerative change in the hematopoietic bone marrow and is a rare well recognized pathological entity. It was earlier described mainly in association with anorexia nervosa and psychiatric eating disorders, but recently it has been reported in ulcerative colitis, tuberculosis, chronic renal diseases, immuno suppressed states (mainly HIV infection), malignancies and Kala azar. Treatment is based on treating the underlying disease. Our objective was to study the epidemiology and pathogenesis of diseases causing gelatinous transformation of bone marrow, at a tertiary center level. A prospective study was conducted on 732 samples of bone marrow aspirate with the aim of identifying gelatinous transformation in bone marrow aspirates which was confirmed by Alcian blue stain at pH 2.5. The presence of this material was correlated with the hematological profile of the patient, the presenting signs and symptoms and provisional clinical diagnosis at initial visit. Incidence of gelatinous transformation was calculated to be nearly 4.8 % and the condition was more common in males (23) as compared to females (12) (Male:Female = 2:1). Forty percent of the cases were seen in children followed by 37 % in adolescents and young adults. The older individuals comprised only 23 % of the cases. The bone marrow was hypocellular in 21 (60 %), normocellular in 10 (28.5 %) and hypercellular in four cases (11.5 %). Five cases with GTBM progressed to aplastic anaemia of which three were in children.
References
Bohm J (2000) Gelatinous transformation of the bone marrow: the spectrum of underlying diseases. Am J Surg Pathol 24:56–65
Yamamoto M, Belmont HM, Utsunonmiya M et al (2009) Gelatinous transformation of the bone marrow in systemic lupus erythematosus. Lupus 18:1108–1111
Chen S, Hung I, Jaing T, Sun C (2004) Gelatinous degeneration of the bone marrow in anorexia nervosa. Chang Gung Med J 27:845–849
Wagner S, Wood S, Amess JAL (1988) Pancytopenia in a patient receiving home intravenous nutrition. Eur J Clin Nutr 42:1029–1034
Yamamoto M, Belmont HM, Utsunonmiya M et al (2009) Gelatinous transformation of the bone marrow in systemic lupus erythematosus. Lupus 18:1108–1111
Sasiki Y, Yamagishi F, Yagi T, Mizutani F (1999) A case of pulmonary tuberculosis case with pancytopenia accompanied to bone marrow gelatinous transformation. Kekkaku 74:361–364
Mathew M, Mathews I, Manohar C et al (2001) Gelatinous transformation of bone marrow following chemotherapy for myeloma. Indian J Pathol Microbiol 44:53–54
Sen R, Singh S, Singh H, Gupta A, Sen J (2003) Clinical profile in gelatinous bone marrow transformation. J Assoc Phys India 51:585–588
Leguit RJ, van den Tweel JG (2010) The pathology of bone marrow failure. Histopathology 57:655–670
Stroup JS, Stephens JR, Baker DL (2007) Gelatinous bone marrow in an HIV-positive patient. Proc (Bayl Univ Med Cent) 20(3):254–256
Bohm J, Schmitt-Graff A (2000) Gelatinous bone marrow transformation in a case of idiopathic myelofibrosis: a morphological paradox. Pathology 196:775–779
Jain R, Singh ZN, Khurana N, Singh T (2005) Gelatinous transformation of bone marrow: a study of 43 cases. Indian J Pathol Microbiol 48:1–3
Meshram II, Arlappa N, Balakrishna N, Mallikharjuna Rao K, Laxmaiah A, Brahmam GN (2012) Trends in the prevalence of undernutrition, nutrient and food intake and predictors of undernutrition among under five year tribal children in India. Asia Pac J Clin Nutr 21(4):568–576
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Singh, S., Gupta, M., Singh, G. et al. Gelatinous Transformation of Bone Marrow: A Prospective Tertiary Center Study, Indicating Varying Trends in Epidemiology and Pathogenesis. Indian J Hematol Blood Transfus 32 (Suppl 1), 358–360 (2016). https://doi.org/10.1007/s12288-015-0514-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12288-015-0514-5